Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Becker, JC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schrama, D; Straten, PT; Fischer, WH; McLellan, AD; Brocker, EB; Reisfeld, RA; Becker, JC
      Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue

      IMMUNITY
    2. Pohle, T; Becker, JC; Markmann, A; Lugering, N; Pauels, HG; Konturek, JW; Domschke, W
      Aspirin effects on gastric epithelial cell proliferation and cytokine expression

      MICROSCOPY RESEARCH AND TECHNIQUE
    3. Wack, C; Becker, JC; Brocker, EB; Lutz, WK; Fischer, WH
      Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model

      MELANOMA RESEARCH
    4. Pohle, T; Brzozowski, T; Becker, JC; van der Voort, IR; Markmann, A; Konturek, SJ; Moniczewski, A; Domschke, W; Konturek, JW
      Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C (vol 15, pg 677, 2001)

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    5. Pohle, T; Brzozowski, T; Becker, JC; Van der Voort, IR; Markmann, A; Konturek, SJ; Moniczewski, A; Domschke, W; Konturek, JW
      Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    6. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
      Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression

      INTERNATIONAL JOURNAL OF CANCER
    7. Terheyden, P; Rickert, S; Kampgen, E; Munnich, S; Hofmann, UB; Brocker, EB; Becker, JC
      Nevus of Ota and choroidal melanoma

      HAUTARZT
    8. Straten, PT; Guldberg, P; Schrama, D; Andersen, MH; Moerch, U; Seremet, T; Siedel, C; Reisfeld, RA; Becker, JC
      In situ cytokine therapy: redistribution of clonally expanded T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    9. Andersen, MH; Pedersen, LO; Becker, JC; Straten, PT
      Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

      CANCER RESEARCH
    10. Schrama, D; Andersen, MH; Terheyden, P; Schroder, L; Pedersen, LO; Straten, PT; Becker, JC
      Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patients

      CANCER RESEARCH
    11. Andersen, MH; Pedersen, LO; Capeller, B; Brocker, EB; Becker, JC; Straten, PT
      Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

      CANCER RESEARCH
    12. Straten, PT; Becker, JC; Zeuthen, J; Guldberg, P
      T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis - Analysis of clonal T-cell responses in melanoma

      MELANOMA TECHNIQUES AND PROTOCOLS: MOLECULAR DIAGNOSIS, TREATMENT, AND MONITORING
    13. Straten, PT; Kirkin, AF; Siim, E; Dahlstrom, K; Drzewiecki, KT; Seremet, T; Zeuthen, J; Becker, JC; Guldberg, P
      Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cellclonotypes that are lost during in vitro culture

      CLINICAL IMMUNOLOGY
    14. Terheyden, P; Becker, JC; Kampgen, E; Brocker, EB
      Sequential interferon-alpha 2b, interleukin-2 and fotemustine for patientswith metastatic melanoma

      MELANOMA RESEARCH
    15. Termeer, CC; Schirrmacher, V; Brocker, EB; Becker, JC
      Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells

      CANCER GENE THERAPY
    16. Moerch, U; Schrama, D; Guldberg, P; Seremet, T; Zeuthen, J; Becker, JC; Straten, PT
      Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    17. Becker, JC; Kampgen, E; Brocker, EB
      Classical chemotherapy for metastatic melanoma

      CLINICAL AND EXPERIMENTAL DERMATOLOGY
    18. Suchanek, TH; Richerson, PJ; Flanders, JR; Nelson, DC; Mullen, LH; Brister, LL; Becker, JC
      Monitoring inter-annual variability reveals sources of mercury contamination in Clear Lake, California

      ENVIRONMENTAL MONITORING AND ASSESSMENT
    19. Becker, JC; Straten, PT
      T-cell clonality in immune responses

      IMMUNOLOGY TODAY
    20. Hofmann, UB; Westphal, JR; Zendman, AJW; Becker, JC; Ruiter, DJ; van Muijen, GNP
      Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression

      JOURNAL OF PATHOLOGY
    21. Hofmann, UB; Westphal, JR; Waas, ET; Becker, JC; Ruiter, DJ; van Muijen, GNP
      Coexpression of integrin alpha(v)beta(3) and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    22. Vetter, CS; Straten, PT; Terheyden, P; Zeuthen, J; Brocker, EB; Becker, JC
      Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    23. Straten, PT; Guldberg, P; Moerch, U; Becker, JC
      Anti-melanocyte T cell responses - Methodology versus biology

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    24. Terheyden, P; Straten, PT; Brocker, EB; Kampgen, E; Becker, JC
      CD40-ligated dendritic cells effectively expand melanoma-specific CD8(+) CTLs and CD4(+) IFN-gamma-producing T cells from tumor-infiltrating lymphocytes

      JOURNAL OF IMMUNOLOGY
    25. Becker, JC; Vetter, CS; Schrama, D; Brocker, EB; Straten, PT
      Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node

      EUROPEAN JOURNAL OF IMMUNOLOGY
    26. Becker, JC; Nitzberg, B; Van der Wijngaart, RF; Yarrow, M
      Predicting price performance trade-offs for Whitney: A commodity computingcluster

      JOURNAL OF SUPERCOMPUTING
    27. Conrad, CT; Ernst, NR; Dummer, W; Brocker, EB; Becker, JC
      Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    28. Fischer, WH; Straten, PT; Terheyden, P; Becker, JC
      Function and dysfunction of CD4(+) T cells in the immune response to melanoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    29. Straten, PT; Becker, JC; Guldberg, P; Zeuthen, J
      In situ T cells in melanoma

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    30. Fischer, H; Becker, JC; Boknik, P; Huber, V; Luss, H; Neumann, J; Schmitz, W; Domschke, W; Konturek, JW
      Expression of endothelial cell-derived nitric oxide synthase (eNOS) is increased during gastric adaptation to chronic aspirin intake in humans

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    31. Fischer, H; Becker, JC; Boknik, P; Huber, V; Luss, H; Neumann, J; Schmitz, W; Domschke, W; Stachura, J; Konturek, JW
      Expression of constitutive nitric oxide synthase in rat and human gastrointestinal tract

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    32. Becker, JC; Guldberg, P; Zeuthen, J; Brocker, EB; Straten, PT
      Accumulation of identical T cells in melanoma and vitiligo-like leukoderma

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    33. Terheyden, P; Siedel, C; Merkel, A; Kampgen, E; Brocker, EB; Becker, JC
      Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    34. Straten, PT; Guldberg, P; Gronbaek, K; Hansen, MR; Kirkin, AF; Seremet, T; Zeuthen, J; Becker, JC
      In situ T cell responses against melanoma comprise high numbers of locallyexpanded T cell clonotypes

      JOURNAL OF IMMUNOLOGY
    35. Hursting, MJ; Zehnder, JL; Joffrion, JL; Becker, JC; Knappenberger, GD; Schwarz, RP
      The international normalized ratio during concurrent warfarin and argatroban anticoagulation: Differential contributions of each agent and effects ofthe choice of thromboplastin used

      CLINICAL CHEMISTRY
    36. Becker, JC; Brocker, EB
      Immunology of cutaneous melanoma

      IMMUNOLOGY OF THE SKIN AND THE EYE
    37. TERHEYDEN P; HORNSCHUH B; KARL S; BECKER JC; BROCKER EB
      LICHEN-PLANUS ASSOCIATED WITH BECKERS NEVUS

      Journal of the American Academy of Dermatology
    38. LODE HN; XIANG R; BECKER JC; GILLIES SD; REISFELD RA
      IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY

      Pharmacology & therapeutics (Oxford)
    39. BECKER JC; LIERSCH R; TAUTZ C; SCHLUETER B; ANDLER W
      SHAKEN BABY SYNDROME - REPORT ON 4 PAIRS OF TWINS

      Child abuse & neglect
    40. FISCHER H; HUBER V; BECKER JC; BOKNIK P; LUSS H; NEUMANN J; SCHMITZ W; DOMSCHKE W; KONTUREK JW
      THE EFFECT OF HELICOBACTER-PYLORI INFECTION ON GASTRIC ADAPTATION TO CHRONIC ASPIRIN INTAKE IN MAN

      Naunyn-Schmiedeberg's archives of pharmacology
    41. STRATEN PT; GULDBERG P; SEREMET T; REISFELD RA; ZEUTHEN J; BECKER JC
      ACTIVATION OF PREEXISTING T-CELL CLONES BY TARGETED INTERLEUKIN-2 THERAPY

      Proceedings of the National Academy of Sciences of the United Statesof America
    42. BECKER JC; SCHULTZ RE
      AXIOMS FOR BUNDLE TRANSFERS AND TRACES

      Mathematische Zeitschrift
    43. WAGNER SN; SCHULTEWOLTER T; WAGNER C; BRIEDIGKEIT L; BECKER JC; KWASNICKA HM; GOOS M
      IMMUNE-RESPONSE AGAINST HUMAN PRIMARY MALIGNANT-MELANOMA - A DISTINCTCYTOKINE MESSENGER-RNA PROFILE ASSOCIATED WITH SPONTANEOUS REGRESSION

      Laboratory investigation
    44. MAYNARD LJ; KELSEY TW; LEMBECK SM; BECKER JC
      EARLY EXPERIENCE WITH PENNSYLVANIA AGRICULTURAL CONSERVATION EASEMENTPROGRAM

      Journal of soil and water conservation
    45. BECKER JC; GULDBURG P; ZEUTHEN J; BROCKER EB; STRATEN PT
      IN-SITU DETECTION OF A CLONAL T-CELL RESPONSE DIRECTED AGAINST NEOPLASTIC AS WELL AS NORMAL MELANOCYTIC CELLS

      Journal of investigative dermatology
    46. TERHEYDEN P; KAMPGEN E; RUNGER TM; BROCKER EB; BECKER JC
      IMMUNOCHEMOTHERAPY OF METASTATIC UVEAL MELANOMA WITH INTERFERON-ALPHA-2B, INTERLEUKIN-2, AND FOTEMUSTINE - CASE-REPORTS AND LITERATURE-REVIEW

      Hautarzt
    47. TRCKA J; KAMPGEN E; BECKER JC; SCHWAAF A; BROCKER EB
      IMMUNOCHEMOTHERAPY OF METASTATIC MALIGNAN T-MELANOMA WITH EPIFOCAL DNCB AND SYSTEMIC DTIC

      Hautarzt
    48. TRCKA J; KAMPGEN E; BECKER JC; BROCKER EB
      EPIFOCAL IMMUNOTHERAPY WITH DNCB COMBINED WITH SYSTEMIC DTIC-CHEMOTHERAPY IS A WELL TOLERATED, IN EXPENSIVE AND EFFECTIVE TREATMENT OF METASTATIC MELANOMA

      British Journal of Cancer
    49. BECKER JC; TERHEYDEN P; BROCKER EB
      MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA

      Melanoma research
    50. REISFELD RA; BECKER JC; GILLIES SD
      IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA

      Melanoma research
    51. BECKER JC; BROCKER EB; REISFELD RA
      IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY

      European journal of cancer
    52. BECKER JC; BLOEBAUM CL; HULME KF
      DISTRIBUTED COMPUTING FOR MULTIDISCIPLINARY DESIGN OPTIMIZATION USINGJAVA

      Structural optimization
    53. HURSTING MJ; BECKER JC; LEWIS BE; IQBAL O; WALENGA JM; FERGUSON JJ
      DIFFERENTIAL-EFFECTS OF ARGATROBAN AND HEPARIN ON HEMOCHRON AND HEMOTEC ACTIVATED CLOTTING TIMES IN PATIENTS UNDERGOING CORONARY INTERVENTIONAL PROCEDURES

      Journal of the American College of Cardiology
    54. AHSAN A; AHMAD S; IQBAL O; SCHWARZ R; KNAPPENBERGER G; JOFFRION J; BECKER JC; MESSMORE H
      COMPARATIVE-STUDIES ON THE BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIESOF A MAJOR METABOLITE OF ARGATROBAN (M1) - POTENTIAL CLINICAL IMPLICATIONS

      Thrombosis and haemostasis
    55. HURSTING MJ; BECKER JC; JOFFRION JL; KNAPPENBERGER GD; SCHWARZ RP
      EFFECT OF HEPATIC-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN

      Thrombosis and haemostasis
    56. AHMAD S; AHSAN A; GEORGE M; WYMA D; SCHWARZ R; KNAPPENBERGER G; JOFFRION J; BECKER JC; MESSMORE H
      PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN IN PATIENTS UNDERGOING ANTICOAGULANT TREATMENT AND CORONARY ANGIOPLASTY

      Thrombosis and haemostasis
    57. FISCHER H; BECKER JC; BOKNIK P; HUBER V; KONTUREK JW; LUSS H; NEUMANN J; SCHMITZ W; DOMSCHKE W
      EXPRESSION OF NITRIC-OXIDE SYNTHASE (NOS) IN HUMAN AND RAT GASTRIC TISSUE

      Naunyn-Schmiedeberg's archives of pharmacology
    58. BECKER JC; BROCKER EB; REISFELD RA
      IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY

      Journal of investigative dermatology
    59. BECKER JC; HURSTING MJ; JOFFRION JL; KNAPPENBERGER GD; LEWIS BE; SCHWARZ RP
      CLINICAL EFFECT OF CONCURRENT WARFARIN ON THE EFFICACY OF ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA

      Blood
    60. HURSTING MJ; BECKER JC; JOFFRION JL; KNAPPENBERGER GD; SCHWARZ RP
      MONITORING WARFARIN DURING CONCURRENT ARGATROBAN THERAPY IN HEALTHY-VOLUNTEERS - USE OF THE INTERNATIONAL NORMALIZED RATIO VERSUS FACTOR-X BY AMIDOLYTIC ASSAY

      Blood
    61. HURSTING MJ; BECKER JC; JOFFRION JL; KNAPPENBERGER GD; SCHWARZ RP
      PREDICTING WARFARINS CONTRIBUTION TO THE INTERNATIONAL NORMALIZATION RATIO DURING CONCURRENT ARGATROBAN THERAPY

      Blood
    62. BECKER JC
      A MEASURE OF MALPRACTICE, MEDICAL INJURY, MALPRACTICE LITIGATION, ANDPATIENT COMPENSATION - WEILER,PC, HIATT,HH, NEWHOUSE,JP, JOHNSON,WG, BRENNAN,TA, LEAPE,LL

      The Journal of rural health
    63. PANCOOK JD; BECKER JC; GILLIES SD; REISFEID RA
      ERADICATION OF ESTABLISHED HEPATIC HUMAN NEUROBLASTOMA METASTASES IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY BY ANTIBODY-TARGETED INTERLEUKIN-2

      Cancer immunology and immunotherapy
    64. BECKER JC; PANCOOK JD; GILLIES SD; MENDELSOHN J; REISFELD RA
      ERADICATION OF HUMAN HEPATIC AND PULMONARY MELANOMA METASTASES IN SCID MICE BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    65. BECKER JC; VARKI N; GILLIES SD; FURUKAWA K; REISFELD RA
      AN ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN OVERCOMES TUMOR HETEROGENEITY BY INDUCTION OF A CELLULAR IMMUNE-RESPONSE

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. BECKER JC; VARKI N; BROCKER EB; REISFELD RA
      LYMPHOCYTE-MEDIATED ALOPECIA IN C57BL 6 MICE FOLLOWING SUCCESSFUL IMMUNOTHERAPY FOR MELANOMA/

      Journal of investigative dermatology
    67. BECKER JC; PANCOOK JD; GILLIES SD; FURUKAWA K; REISFELD RA
      T-CELL-MEDIATED ERADICATION OF MURINE METASTATIC MELANOMA INDUCED BY TARGETED INTERLEUKIN-2 THERAPY

      The Journal of experimental medicine
    68. STRATEN P; BECKER JC; SEREMET T; BROCKER EB; ZEUTHEN J
      CLONAL T-CELL RESPONSES IN TUMOR-INFILTRATING LYMPHOCYTES FROM BOTH REGRESSIVE AND PROGRESSIVE REGIONS OF PRIMARY HUMAN-MALIGNANT MELANOMA

      The Journal of clinical investigation
    69. STROMBLAD S; BECKER JC; YEBRA M; BROOKS PC; CHERESH DA
      SUPPRESSION OF P53 ACTIVITY AND P21(WAF1 CIP1) EXPRESSION BY VASCULARCELL INTEGRIN ALPHA-V-BETA-3 DURING ANGIOGENESIS/

      The Journal of clinical investigation
    70. BECKER JC; VARKI N; GILLIES SD; FURUKAWA K; REISFELD RA
      LONG-LIVED AND TRANSFERABLE TUMOR-IMMUNITY IN MICE AFTER TARGETED INTERLEUKIN-2 THERAPY

      The Journal of clinical investigation
    71. MONTGOMERY AMP; BECKER JC; SIU CH; LEMMON VP; CHERESH DA; PANCOOK JD; ZHAO XN; REISFELD RA
      HUMAN NEURAL CELL-ADHESION MOLECULE L1 AND RAT HOMOLOG NILE ARE LIGANDS FOR INTEGRIN ALPHA(V)BETA(3)

      The Journal of cell biology
    72. REISFELD RA; GILLIES SD; MENDELSOHN J; VARKI NM; BECKER JC
      INVOLVEMENT OF B-LYMPHOCYTES IN THE GROWTH-INHIBITION OF HUMAN PULMONARY MELANOMA METASTASES IN ATHYMIC NU NU MICE BY IN ANTIBODY-LYMPHOTOXIN FUSION PROTEIN/

      Cancer research
    73. YEBRA M; FILARDO EJ; BAYNA EM; KAWAHARA E; BECKER JC; CHERESH DA
      INDUCTION OF CARCINOMA CELL-MIGRATION ON VITRONECTIN BY NF-KAPPA-B-DEPENDENT GENE-EXPRESSION

      Molecular biology of the cell
    74. DUMMER W; BECKER JC; SCHWAAF A; LEVERKUS M; MOLL T; BROCKER EB
      ELEVATED SERUM LEVELS OF INTERLEUKIN-10 IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA

      Melanoma research
    75. REISFELD RA; BECKER JC; PANCOOK JD
      RECOMBINANT ANTIBODY-CYTOKINE FUSION PROTEINS FOR CANCER-IMMUNOTHERAPY

      Experimental hematology
    76. BECKER JC; BRABLETZ T; KIRCHNER T; CONRAD CT; BROCKER EB; REISFELD RA
      NEGATIVE TRANSCRIPTIONAL REGULATION IN ANERGIC T-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    77. BECKER JC; NIKROO A; BRABLETZ T; REISFELD RA
      DNA LOOPS INDUCED BY COOPERATIVE BINDING OF TRANSCRIPTIONAL ACTIVATORPROTEINS AND PREINITIATION COMPLEXES

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. BECKER JC; NIKROO A; BRABLETZ T; REISFELD RA
      DNA CONFORMATIONAL-CHANGES IN TRANSCRIPTION COMPLEXES

      Journal of investigative dermatology
    79. DUMMER W; BECKER JC; SCHWAAF A; LEVERKUS M; MOLL T; BROCKER EB
      INTERLEUKIN-10 IN HUMAN-MALIGNANT MELANOMA

      Journal of investigative dermatology
    80. BROCKER EB; BECKER JC
      IMMUNOLOGY OF MELANOMA

      Hautarzt
    81. DUMMER R; GORE ME; HANCOCK BW; GUILLOU PJ; GROBBEN HC; BECKER JC; OSKAM R; DIELEMAN JP; BURG G
      A MULTICENTER PHASE-II CLINICAL-TRIAL USING DACARBAZINE AND CONTINUOUS-INFUSION INTERLEUKIN-2 FOR METASTATIC MELANOMA - CLINICAL-DATA AND IMMUNOMONITORING

      Cancer
    82. BECKER JC; CZERNY C; BROCKER EB
      MAINTENANCE OF CLONAL ENERGY BY ENDOGENOUSLY PRODUCED IL-10

      International immunology
    83. SCHULTZ ES; DUMMER R; BECKER JC; ZILLIKENS D; BURG G
      INFLUENCE OF VARIOUS CYTOKINES ON THE INTERLEUKIN-2-DEPENDENT LYSIS OF MELANOMA-CELLS IN-VITRO

      Archives of dermatological research
    84. BECKER JC; GILLITZER R; BROCKER EB
      A MEMBER OF THE MELANOMA ANTIGEN-ENCODING GENE (MAGE) FAMILY IS EXPRESSED IN HUMAN SKIN DURING WOUND-HEALING

      International journal of cancer
    85. BECKER JC; WINKLER B; KLINGERT S; BROCKER EB
      ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED WITH IMMUNOTHERAPY FOR PATIENTS WITH MELANOMA

      Cancer
    86. BECKER JC; BRABLETZ T; CZERNY C; TERMEER C; BROCKER EB
      TUMOR ESCAPE MECHANISMS FROM IMMUNOSURVEILLANCE - INDUCTION OF UNRESPONSIVENESS IN A SPECIFIC MHC-RESTRICTED CD4-CELL CLONE BY THE AUTOLOGOUS MHC CLASS-II+ MELANOMA( HUMAN T)

      International immunology
    87. BECKER JC; SCHWINN A; DUMMER R; BURG G; BROCKER EB
      LESION-SPECIFIC ACTIVATION OF CLONED HUMAN TUMOR-INFILTRATING LYMPHOCYTES BY AUTOLOGOUS TUMOR-CELLS - INDUCTION OF PROLIFERATION AND CYTOKINE PRODUCTION

      Journal of investigative dermatology
    88. BECKER JC; TERMEER C; SCHMIDT RE; BROCKER EB
      SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 INHIBITS MHC-RESTRICTED SPECIFIC T-CELL TUMOR INTERACTION

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:39:59